BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32467348)

  • 1. Comparison of Tissue-Based Molecular Markers in Younger versus Older Patients with Colorectal Neoplasia.
    Limburg PJ; Mahoney DW; Ahlquist DA; Allawi HT; Johnson SC; Kaiser M; Katerov VE; Statz S; Graham RP; Foote PH; Doering KA; Burger KN; Lidgard GP; Kisiel JB
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1570-1576. PubMed ID: 32467348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions.
    Gagrat ZD; Krockenberger M; Bhattacharya A; Gagrat BZ; Leduc CM; Matter MB; Fourrier KD; Mahoney DW; Edwards V DK; Lidgard GP; Limburg PJ; Johnson SC; Domanico MJ; Kisiel JB
    Cancer Prev Res (Phila); 2024 Mar; 17(3):119-126. PubMed ID: 38224564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
    Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
    Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study.
    Imperiale TF; Kisiel JB; Itzkowitz SH; Scheu B; Duimstra EK; Statz S; Berger BM; Limburg PJ
    Cancer Prev Res (Phila); 2021 Apr; 14(4):489-496. PubMed ID: 33436397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data.
    Anderson JC; Robinson CM; Hisey W; Limburg PJ; Butterly LF
    Cancer Prev Res (Phila); 2022 Jul; 15(7):455-464. PubMed ID: 35378546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
    Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
    Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).
    Heigh RI; Yab TC; Taylor WR; Hussain FT; Smyrk TC; Mahoney DW; Domanico MJ; Berger BM; Lidgard GP; Ahlquist DA
    PLoS One; 2014; 9(1):e85659. PubMed ID: 24465639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplasia Diagnosis After Multi-target Stool DNA Is Enhanced Among Lowest Baseline Detectors.
    Ebner DW; Burger KN; Mahoney DW; Broderick BT; Eckmann JD; Devens ME; Lowrie KL; League JB; Bering J; Kahn A; Rodriguez EA; Prichard DO; Wallace MB; Kane SV; Leighton JA; Buttar NS; Rutten LJF; Gurudu SR; Kisiel JB
    Dig Dis Sci; 2023 Sep; 68(9):3721-3731. PubMed ID: 37486445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People.
    Redwood DG; Asay ED; Blake ID; Sacco PE; Christensen CM; Sacco FD; Tiesinga JJ; Devens ME; Alberts SR; Mahoney DW; Yab TC; Foote PH; Smyrk TC; Provost EM; Ahlquist DA
    Mayo Clin Proc; 2016 Jan; 91(1):61-70. PubMed ID: 26520415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry.
    Anderson JC; Hisey WM; Robinson CM; Limburg PJ; Kneedler BL; Butterly LF
    Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):226-232. PubMed ID: 36409472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
    Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
    J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
    [No Abstract]   [Full Text] [Related]  

  • 15. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study.
    Imperiale TF; Lavin PT; Marti TN; Jakubowski D; Itzkowitz SH; May FP; Limburg PJ; Sweetser S; Daghestani A; Berger BM
    Cancer Prev Res (Phila); 2023 Feb; 16(2):89-97. PubMed ID: 36205504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing.
    Voss JK; Ebner DW; Burger KN; Mahoney DW; Devens ME; Lowrie KL; Kisiel JB
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2399-2406. PubMed ID: 36621751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography.
    Deiss-Yehiely N; Graffy PM; Weigman B; Hassan C; Matkowskyj KA; Pickhardt PJ; Weiss JM
    AJR Am J Roentgenol; 2022 Apr; 218(4):670-676. PubMed ID: 34755523
    [No Abstract]   [Full Text] [Related]  

  • 19. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry.
    Anderson JC; Robinson CM; Hisey WM; Edwards DK; Kneedler BL; Berger BM; Butterly LF
    J Clin Gastroenterol; 2022 May-Jun 01; 56(5):419-425. PubMed ID: 33973962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.